Warner Music helps MediMusic continue to push music in medicine with partnership

Warner Music has begun to embark on its first venture into the realm of medicine with MediMusic to develop therapeutic tools involving music to help those dealing with medical ailments. The partnership aims to develop AI tools dealing with music to help patients deal with issues such as pain, anxiety, and stress.

Warner Music’s deal is set to elevate through clinical trials in which music is harnessed through personalized playlists to help those suffering with a spectrum of pain, anxiety, and stress. With MediMusic’s emphasis on AI in music and machine learning, the partnership will help bring to fruition evidence-based playlists specifically created for each unique client or patient to help in healthcare outcomes.

The trials intend to create an AI powered by machine learning that hones in not only how well the AI helps a patient through their vitals, but also takes these vitals into account as a benchmark for how well the system is adapting to the needs of patients. By using associated physiological monitors such as wrist heart-rate monitors, the AI can track how helpful the AI is to each specific patient as well as adapt on the fly to the needs of the patient. Using MediBeat (MediMusic’s original music streamer used specifically to power the AI and interface with physiological monitoring systems), the company monitors both desired and undesired effects with a benchmark they term ‘Digital Drip’ which utilizes the AI to change out non-preferred tracks to something that the patient seems to respond better to to promote the most optimized relaxation for every patient.

The MediMusic AI sets out to curate a 20-minute long playlist designed to slow down elevated heart rates and decrease cortisol levels whilst simultaneously endorsing the release of relaxing hormones such as dopamine and oxytocin by promoting and presenting music that physiologically seems to agree with each unique patient through the vitals being monitored in real-time. This approach is used in hopes of decreasing the reliance patients have on pharmaceutical relief in place of more holistic approaches using modern technology to help surpass less technological approaches to health care.

With the support of Warner Music, MediMusic is planning to continue its research in closed randomized controlled trials throughout both the US and the UK.